|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
264,900,000 |
Market
Cap: |
8.27(B) |
Last
Volume: |
49,305,461 |
Avg
Vol: |
5,854,790 |
52
Week Range: |
$4.32 - $31.23 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 606 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile ImmunoGen is a clinical-stage biotechnology company focused on developing the antibody-drug conjugates (ADCs). Co.'s main program is mirvetuximab, an ADC targeting folate receptor alpha, a cell-surface protein overexpressed in a number of epithelial tumors, including ovarian, endometrial, and non-small-cell lung cancers. Pivekimab sunirine is an ADC comprised of an antibody designed to target CD123 with site-specific conjugation to a DNA-alkylating payload of the IGN (indolinobenzodiazepine pseudodimer) class. Co.'s pipeline program, IMGC936, is an ADC that is designed to target ADAM9, an enzyme overexpressed in a range of solid tumors and implicated in tumor progression and metastasis.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
39,348 |
1,060,446 |
4,785,085 |
4,785,085 |
Total Sell Value |
$1,152,494 |
$23,992,060 |
$86,338,289 |
$86,338,289 |
Total People Sold |
4 |
5 |
5 |
5 |
Total Sell Transactions |
4 |
17 |
26 |
26 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Goldberg Mark Alan |
|
|
2023-12-29 |
4 |
A |
$29.65 |
$16,871 |
D/D |
569 |
60,720 |
|
- |
|
Lentini Renee |
VP & PRIN ACCTG OFFICER |
|
2023-12-29 |
4 |
A |
$16.01 |
$7,477 |
D/D |
467 |
8,919 |
|
- |
|
Coen Stacy Ann |
SVP & CHIEF BUSINESS OFFICER |
|
2023-12-29 |
4 |
A |
$16.01 |
$5,876 |
D/D |
367 |
63,507 |
|
- |
|
Coen Stacy Ann |
SVP & CHIEF BUSINESS OFFICER |
|
2023-12-29 |
4 |
OE |
$5.32 |
$159,600 |
D/D |
30,000 |
63,140 |
|
- |
|
Lentini Renee |
VP & PRIN ACCTG OFFICER |
|
2023-12-26 |
4 |
AS |
$29.74 |
$194,738 |
D/D |
(6,548) |
8,452 |
|
5% |
|
Lentini Renee |
VP & PRIN ACCTG OFFICER |
|
2023-12-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
|
- |
|
Wingrove Theresa |
SVP OF REGULATORY AFFAIRS |
|
2023-12-15 |
4 |
AS |
$29.40 |
$3,452,883 |
D/D |
(117,445) |
2,811 |
|
6% |
|
Wingrove Theresa |
SVP OF REGULATORY AFFAIRS |
|
2023-12-15 |
4 |
OE |
$4.55 |
$603,411 |
D/D |
117,445 |
120,256 |
|
- |
|
Peterson Kristine |
|
|
2023-11-30 |
4 |
AS |
$28.90 |
$578,000 |
D/D |
(20,000) |
0 |
|
6% |
|
Peterson Kristine |
|
|
2023-11-30 |
4 |
OE |
$10.10 |
$231,700 |
D/D |
20,000 |
20,000 |
|
- |
|
Coen Stacy Ann |
SVP & CHIEF BUSINESS OFFICER |
|
2023-11-30 |
4 |
AS |
$29.20 |
$111,719 |
D/D |
(3,826) |
33,140 |
|
6% |
|
Wingrove Theresa |
SVP OF REGULATORY AFFAIRS |
|
2023-11-30 |
4 |
AS |
$28.95 |
$4,760,075 |
D/D |
(164,424) |
2,811 |
|
6% |
|
Wingrove Theresa |
SVP OF REGULATORY AFFAIRS |
|
2023-11-30 |
4 |
OE |
$10.65 |
$1,755,418 |
D/D |
164,424 |
167,235 |
|
- |
|
Wingrove Theresa |
SVP OF REGULATORY AFFAIRS |
|
2023-11-29 |
4 |
AS |
$16.66 |
$113,155 |
D/D |
(6,792) |
2,811 |
|
94% |
|
Wingrove Theresa |
SVP OF REGULATORY AFFAIRS |
|
2023-11-29 |
4 |
OE |
$10.65 |
$72,335 |
D/D |
6,792 |
9,603 |
|
- |
|
Coen Stacy Ann |
SVP & CHIEF BUSINESS OFFICER |
|
2023-11-17 |
4 |
AS |
$16.05 |
$1,255,479 |
D/D |
(78,223) |
36,966 |
|
94% |
|
Coen Stacy Ann |
SVP & CHIEF BUSINESS OFFICER |
|
2023-11-17 |
4 |
OE |
$4.92 |
$595,441 |
D/D |
78,223 |
115,189 |
|
- |
|
Coen Stacy Ann |
SVP & CHIEF BUSINESS OFFICER |
|
2023-11-16 |
4 |
AS |
$16.01 |
$65,641 |
D/D |
(4,100) |
36,966 |
|
100% |
|
Coen Stacy Ann |
SVP & CHIEF BUSINESS OFFICER |
|
2023-11-16 |
4 |
OE |
$4.92 |
$22,665 |
D/D |
4,100 |
41,066 |
|
- |
|
Coen Stacy Ann |
SVP & CHIEF BUSINESS OFFICER |
|
2023-11-15 |
4 |
AS |
$16.01 |
$420,839 |
D/D |
(26,286) |
36,966 |
|
100% |
|
Coen Stacy Ann |
SVP & CHIEF BUSINESS OFFICER |
|
2023-11-15 |
4 |
OE |
$4.92 |
$144,008 |
D/D |
26,286 |
63,252 |
|
- |
|
Wingrove Theresa |
SVP OF REGULATORY AFFAIRS |
|
2023-11-15 |
4 |
AS |
$15.85 |
$2,642,591 |
D/D |
(166,725) |
2,811 |
|
100% |
|
Wingrove Theresa |
SVP OF REGULATORY AFFAIRS |
|
2023-11-15 |
4 |
OE |
$4.55 |
$758,599 |
D/D |
166,725 |
169,536 |
|
- |
|
Wingrove Theresa |
SVP OF REGULATORY AFFAIRS |
|
2023-11-07 |
4 |
AS |
$16.66 |
$325,153 |
D/D |
(19,517) |
2,811 |
|
95% |
|
Wingrove Theresa |
SVP OF REGULATORY AFFAIRS |
|
2023-11-07 |
4 |
OE |
$10.65 |
$207,856 |
D/D |
19,517 |
22,328 |
|
- |
|
257 Records found
|
|
Page 2 of 11 |
|
|